UQD

1.

Global Fund Board approves a small 18th batch of grants from 2017-2019 allocations

2 Apr 2019
Egypt, a non-CCM applicant, receives funding for a new TB/HIV grant

On 22 March 2019, the Global Fund Board approved funding for two country grants and supplementary funding for a third –– for a total value of $11.0 million. Interventions worth $4.1 million were added to the Unfunded Quality Demand (UQD) Register. Domestic commitments for the programs included in the approved country grants amounted to $28.5 million. (See Table 1 for details.)

1.

Global Fund Board approves an additional $16 million from 2017–2019 allocations

19 Mar 2019
Multi-country grant for Southern Africa receives $12 million

On 22 February 2019, the Global Fund Board approved one multi-country grant, one matching funds request and one set of interventions on the Unfunded Quality Demand (UQD) Register –– worth a total of $16.0 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). This was the 17th batch of approvals from the 2017–2019 allocations.

1.

Global Fund Board approves $36 million for country and multicountry grants

25 Feb 2019
Another $66 million was approved for interventions on the UQD Register

On 31 January 2019, the Global Fund Board approved three country grants worth $13.4 million. It also approved two multicountry grants valued at $22.5 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). See Tables 1 and 2 for listings of the country and multi-country grants.

2.

Global Fund Board approves $229 million in funding for country grants

14 Jan 2019
Three multi-country grants valued at $24 million also approved

On 21 December 2018, the Global Fund Board approved 16 country grants worth $229.4 million. It also approved three multi-country grants valued at $24.0 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC).

3.

Global Fund Board gives the Secretariat the green light to prepare proposals for investing in non-eligible countries in crisis (e.g. Venezuela)

12 May 2018
How much the Fund might invest and where the money will come from are still up in the air
The Fund is concerned about the potential impact on eligible countries
7.

Global Fund Board approves funding for two country grants, a multi-country grant and 10 matching funds requests

24 Apr 2018
Fund invests $6 million in the Regional Malaria Elimination Initiative in Mesoamerica and Hispaniola
8.

Nepal’s funding requests to the Global Fund yield three grants to be managed by an international NGO

24 Apr 2018
HIV, TB and malaria grants were approved in March 2018

 

8.

Global Fund Board approves another $102.9 million in funding

3 Apr 2018
Cumulative amount awarded to date: $8.86 billion

7.

Global Fund grants to Thailand aim to strengthen services for key populations and support a successful transition

20 Feb 2018
These may be the final TB and HIV grants to Thailand

On 1 December 2017, acting on the recommendation of the Global Fund’s Grant Approvals Committee (GAC), the Board approved two grants emanating from Thailand’s 2017 Window 2 TB/HIV funding request. The Ministry of Health’s Department of Disease Control will serve as principal recipient (PR) for one grant, totaling $18.0 million.

6.

Global Fund Board approves fifth batch of country grants from 2017-2019 allocations, in the amount of $1.22 billion

23 Jan 2018
Cumulative amount awarded to date: $8.86 billion

On 12 January 2018, the Global Fund Board approved 33 country grants worth $1.22 billion. This was the fifth batch of approvals from the 2017–2019 allocations, and brings the cumulative amount awarded to date to $8.86 billion.

Pages

Subscribe to UQD